Walleye Capital
RVMDW icon

Walleye Capital’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Walleye Capital’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-175,765
Closed -$6.68K – 4968
2025
Q1 		$6.68K Sell
175,765
-173,983
-50% -$21.6K ﹤0.01% 4087
2024
Q4 		$63K Sell
349,748
-2,919
-0.8% -$863 ﹤0.01% 4297
2024
Q3 		$49.4K Hold
352,667
– – ﹤0.01% 4646
2024
Q2 		$36K Sell
352,667
-4,000
-1% -$829 ﹤0.01% 5015
2024
Q1 		$65.1K Sell
356,667
-239,319
-40% -$48.4K ﹤0.01% 4583
2023
Q4 		$197K Buy
+595,986
New +$266K ﹤0.01% 3688

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
SCM
Soros Capital Management New York $230M AUM 83.9% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Walleye Capital's RVMDW Position: Q2 2025 in Review

Walleye Capital sold out of Revolution Medicines Inc Warrant (RVMDW) in Q2 2025, closing a stake of 175,765 shares — an estimated $6.68K sold.

Walleye Capital first reported a position in RVMDW in Q4 2023 and held it in 6 quarters. The position peaked at $197K in Q4 2023. 23 funds tracked by Wall St. Rank hold RVMDW as of Q2 2025.

  • Walleye Capital reported no remaining Revolution Medicines Inc Warrant position as of Q2 2025 after selling out during the quarter.
  • Walleye Capital sold 175,765 Revolution Medicines Inc Warrant shares in Q2 2025, an estimated $6.68K.
  • Walleye Capital first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and held it in 6 quarters.
  • Walleye Capital's Revolution Medicines Inc Warrant position peaked at $197K in Q4 2023.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2025.

Based on Walleye Capital's 13F filing for Q2 2025, filed 13 Aug 2025.